Searched for
SENSODYNE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- Haleon to invest Rs 2,000 crore to set up first India plantHaleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fas...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- On their toes: Brands step up anti-counterfeit drive as fake products flood marketsCompanies are fighting a rising tide of fake goods. Brands from toothpaste to cigarettes are changing packaging and tightening checks. Coun...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...
- Haleon Appoints Former Castrol MD Kedar Lele as India Subcontinent PresidentHaleon has appointed Kedar Lele as president, India subcontinent, succeeding Navneet Saluja. Lele, formerly managing director of Castrol In...
- Sensodyne toothpaste-maker Haleon planning job cutsThe company behind the Sensodyne toothpaste and Advil painkillers was spun off from GSK last year and has more than 24,000 staff globally. ...
- CCPA imposes Rs 10 lakh penalty for misleading ads of SensodyneAn official release on Tuesday stated that advertisements of Sensodyne products which make the claims 'Recommended by dentists worldwide' a...
- CCPA passes order for discontinuation of ads of Sensodyne products in IndiaThe Central Consumer Protection Authority (CCPA) has also passed an order against Naaptol Online Shopping Ltd for misleading advertisements...
- Sensitive toothpaste sales flat so far in FY15 as consumers opt for multi-benefit brandsExperts feel sensitive toothpaste segment hit the mark initially but consumers switched to regular ones after early trials.
- GSK Consumer Healthcare’s G Venkatramani & Rahul Bibhuti made Sensodyne a successful brandWhile Venkatramani spearheaded Sensodyne’s sales, Bibhuti was responsible for bringing it closer to Indian consumers.
- GSKCH rolls out global niche toothpaste brand ParodontaxConsumer and healthcare firm GlaxoSmithKline on Friday announced the national roll out of its second global oral care brand Parodontax – a ...
- GSK's Sensodyne overtakes Colgate in sensitive category within two years of its launchJust two years after its launch in the country, Sensodyne has overtaken Colgate Sensitive to become the top-selling sensitive toothpaste br...
- Colgate moves to protect lead in oral care marketingColgate-Palmolive (India) has upped the ante to protect its turf in this small but growing segment of the Rs 2,700-crore toothpaste market.
- GSK re-enters oral care market with SensodyneSensodyne, GSK's biggest global brand with an annual sales of $750 million, has close to a 10% share of the US toothpaste market.
- GSK Consumer Healthcare enters Indian toothpaste marketFMCG firm GlaxoSmithkline Consumer Healthcare today announced its entry into the Indian oral care market through its global toothpaste bran...
Load More
